Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 771-780 of 10709

Edit search filters
  1. Effects of Aprepitant on Satiation, Gastric Volume, Gastric Accommodation and Gastric Emptying

    Rochester, MN

  2. A Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects with Lewy Body Dementia

    Rochester, MN

  3. Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170)

  4. A Study of Positive Long-Term Functional Outcomes with Early Tracheostomy in Ventilated Stroke Patients

    Jacksonville, FL

  5. A Study of Ovarian Tissue Freezing for the Preservation of Fertility in Children

    Rochester, MN

  6. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease

    Rochester, MN

  7. A Study of Proton Radiation Divided into Fewer Doses for Low Risk Prostate Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  8. A Study of Obinutuzumab to Evaluate the Safety and Tolerability in Hypersensitized Adult Participants with End Stage Renal Disease Awaiting Transplantation

    Rochester, MN

  9. A Study Evaluating a Decision Support Tool for Patients and Caregivers Offered a Heart Assist Device for End Stage Heart Failure

    Rochester, MN

  10. A Study of the Safety and Effectiveness of NP001 for Patients with Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation

    Jacksonville, FL

.

Mayo Clinic Footer